HRGN (Harvard Apparatus Regenerative Technology) Institutional Ownership: 0.00% (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HRGN Harvard Apparatus Regenerative Technology Inc HRGN
13 GF Score
Price $1.52
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Institutional Ownership?

Harvard Apparatus Regenerative Technology HRGN 13 Institutional Ownership is 0.00% as of Aug. 21, 2026. GuruFocus rates HRGN with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Harvard Apparatus Regenerative Technology's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Harvard Apparatus Regenerative Technology's Insider Ownership is 27.49%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Harvard Apparatus Regenerative Technology's Float Percentage Of Total Shares Outstanding is 62.05%.

Harvard Apparatus Regenerative Technology Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Harvard Apparatus Regenerative Technology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Apparatus Regenerative Technology Institutional Ownership Chart

Harvard Apparatus Regenerative Technology Historical Data

The historical data trend for Harvard Apparatus Regenerative Technology can be seen below:

2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30 2018-12-31
Institutional Ownership 1.03 1.03 1.03 0.34 0.34 0.34 0.34 0.34 0.02 0.02
HRGN
13GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvard Apparatus Regenerative Technology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Institutional Ownership of 0.00% as of Aug. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Harvard Apparatus Regenerative Technology and its competitors.
Is Harvard Apparatus Regenerative Technology's Institutional Ownership too high?
Harvard Apparatus Regenerative Technology's current Institutional Ownership is 0.00%. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Institutional Ownership compare to JVA and BRLS?
Harvard Apparatus Regenerative Technology's Institutional Ownership of 0.00% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Consumer Packaged Goods company?
A good Institutional Ownership depends on the Consumer Packaged Goods industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Harvard Apparatus Regenerative Technology and its competitors. Harvard Apparatus Regenerative Technology's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Harvard Apparatus Regenerative Technology (HRGN) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. Harvard Apparatus Regenerative Technology's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Institutional Ownership is 0.00% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
13GF Score

Get the complete analysis for HRGN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price